DDX41 dissolves G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell death

Honghao Bi,Kehan Ren,Pan Wang,Ermin Li,Xu Han,Wen Wang,Jing Yang,Inci Aydemir,Kara Tao,Lucy Godley,Yan Liu,Vipul Shukla,Elizabeth Bartom,Yuefeng Tang,Lionel Blanc,Madina Sukhanova,Peng Ji

DOI: https://doi.org/10.1101/2024.10.14.617891

2024-10-17

Abstract:Deleterious germline DDX41 variants constitute the most common inherited predisposition disorder linked to myeloid neoplasms (MNs). The role of DDX41 in hematopoiesis and how its germline and somatic mutations contribute to MNs remain unclear. Here we show that DDX41 is essential for erythropoiesis but dispensable for the development of other hematopoietic lineages. Using stage-specific Cre models for erythropoiesis, we reveal that Ddx41 knockout in early erythropoiesis is embryonically lethal, while knockout in late-stage terminal erythropoiesis allows mice to survive with normal blood counts. DDX41 deficiency induces a significant upregulation of G-quadruplexes (G4), noncanonical DNA structures that tend to accumulate in the early stages of erythroid precursors. We show that DDX41 co-localizes with G4 on the erythroid genome. DDX41 directly binds to and dissolves G4, which is significantly compromised in MN-associated DDX41 mutants. Accumulation of G4 by DDX41 deficiency induces erythroid genome instability, defects in ribosomal biogenesis, and upregulation of p53. However, p53 deficiency does not rescue the embryonic death of Ddx41 hematopoietic-specific knockout mice. In parallel, genome instability also activates the cGas-Sting pathway, which is detrimental to survival since cGas-deficient and hematopoietic-specific Ddx41 knockout mice are viable without detectable hematologic phenotypes, although these mice continue to show erythroid ribosomal defects and upregulation of p53. These findings are further supported by data from a DDX41 mutated MN patient and human iPSC-derived bone marrow organoids. Our study establishes DDX41 as a G4 dissolver, essential for erythroid genome stability and suppressing the cGAS-STING pathway.

Cancer Biology

What problem does this paper attempt to address?

The main issue this paper attempts to address is the specific role and mechanism of DDX41 in erythropoiesis, particularly how it maintains the stability of the erythroid genome by resolving G-quadruplexes (G4) and prevents cGAS-mediated cell death due to G4 accumulation. Additionally, the study explores how loss-of-function mutations in DDX41 affect erythropoiesis and the relationship between these effects and the development of myeloid neoplasms (MNs).

Specifically, the paper addresses the above issues through the following aspects:

1. **The role of DDX41 in different stages of erythropoiesis**: By constructing mouse models with stage-specific knockout of DDX41, the study found that DDX41 is essential in early erythropoiesis but not in late erythropoiesis. This indicates that DDX41 has different functional importance at different stages of erythropoiesis.

2. **The relationship between DDX41 and G-quadruplexes**: The study shows that DDX41 can directly bind and resolve G-quadruplexes, a process crucial for maintaining erythroid genome stability and inhibiting the activation of the cGAS-STING pathway. Loss-of-function mutations in DDX41 lead to G-quadruplex accumulation, resulting in genomic instability, ribosome biogenesis defects, and p53 upregulation.

3. **The role of the cGAS-STING pathway in DDX41 loss-of-function**: The research reveals that the cGAS-STING pathway, rather than p53 upregulation, plays a key role in ineffective erythropoiesis and cell death caused by DDX41 loss-of-function. The absence of cGAS can completely rescue the embryonic lethality of DDX41-specific knockout mice, and these mice do not exhibit significant anemia or other cytopenias.

4. **Sensitivity of human erythroid cells to DDX41 deficiency**: Using an induced pluripotent stem cell (iPSC)-derived human bone marrow organoid system, the study further validates the sensitivity of human erythroid cells to DDX41 deficiency and how this sensitivity may indirectly affect the surrounding hematopoietic microenvironment through the activation of the cGAS-STING pathway.

In summary, this paper not only delves into the mechanism of DDX41 in erythropoiesis but also provides new insights into how DDX41 mutations promote the development of myeloid neoplasms.